Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tongzhen Xu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
BMC Cancer|April 19, 2024
The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II studyTongzhen Xu, Lingling Feng, Wenjue Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2026
Dose-escalated versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: 9-year Results of a Randomized Phase 2 TrialHaoyue Li, Ningyu Wang, Tongzhen Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 16, 2026
Diabetes and Performance Status Predict Severe, Persistent Radiation Proctitis: Long-term Endoscopic Findings from STELLAR TrialNingyu Wang, Tongzhen Xu, Haoyue Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 7, 2024
Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trialHuiying Ma, Haoyue Li, Tongzhen Xu, et al.
BMC Medicine|February 26, 2026
Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trialTongzhen Xu, Huiying Ma, Wenjue Zhang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
BMC Cancer|April 19, 2024
The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II studyTongzhen Xu, Lingling Feng, Wenjue Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2026
Dose-escalated versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: 9-year Results of a Randomized Phase 2 TrialHaoyue Li, Ningyu Wang, Tongzhen Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 16, 2026
Diabetes and Performance Status Predict Severe, Persistent Radiation Proctitis: Long-term Endoscopic Findings from STELLAR TrialNingyu Wang, Tongzhen Xu, Haoyue Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 7, 2024
Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trialHuiying Ma, Haoyue Li, Tongzhen Xu, et al.
BMC Medicine|February 26, 2026
Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trialTongzhen Xu, Huiying Ma, Wenjue Zhang, et al.
Pageof 2